Real-world outcomes by race in patients (pts) with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Final analysis results from the informCLL registry.

被引：0
|
作者：
Barrientos, Jacqueline Claudia
Sharman, Jeff Porter
Gutierrez, Meghan E.
Wu, Linda
Qureshi, Zaina P.
Raz, Anat
Girardi, Vincent
Naganuma, Maoko
Ghosh, Nilanjan
机构：
[1] Mt Sinai Comprehens Canc Ctr, Miami Beach, FL USA
[2] US Oncol Res, Willamette Valley Canc Inst & Res Ctr, Eugene, OR USA
[3] Lymphoma Res Fdn, New York, NY USA
[4] Janssen, Horsham, PA USA
[5] Janssen Sci Affairs LLC, Horsham, PA USA
[6] Pharmacyclics LLC, San Francisco, CA USA
[7] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7536
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Real-world outcomes following adverse events and dose reduction of first-line ibrutinib in Medicare beneficiaries with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Shadman, Mazyar
    Srivastava, Bhavini P.
    Salkar, Monika
    Saifan, Chadi
    Agatep, Barnabie C.
    Jones, Barton
    Ryan, Olga
    Bacchus, Shaffee
    Stephens, Deborah M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] The Immunophenotype of Prolymphocytoid Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Revisited
    Rathke, S. K.
    Chang, J. C.
    Harrington, A. M.
    Olteanu, H.
    Kroft, S. H.
    MODERN PATHOLOGY, 2013, 26 : 357A - 357A
  • [33] The Immunophenotype of Prolymphocytoid Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Revisited
    Rathke, S. K.
    Chang, J. C.
    Harrington, A. M.
    Olteanu, H.
    Kroft, S. H.
    LABORATORY INVESTIGATION, 2013, 93 : 357A - 357A
  • [34] Real-world Bruton tyrosine kinase inhibitor (BTKi) treatment patterns and outcomes among patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) in US community oncology practices
    Hou, Jing-Zhou
    Blanc, Simon
    Maglinte, Gregory A.
    Vasudevan, Anupama
    Rui, Anna
    Gart, Mike
    Pham, Hoa
    Aton, Lindsay
    Wang, Brandon
    Choksi, Rushir J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] IDELALISIB IN COMBINATION WITH RITUXIMAB IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): REAL-WORLD EXPERIENCE THROUGH AN EARLY ACCESS PROGRAM IN EUROPE AND AUSTRALIA
    Li, J. J.
    Yong, A. S.
    Justicia, J. L.
    Smith, C.
    Delgado, J.
    HAEMATOLOGICA, 2016, 101 : 229 - 229
  • [36] Activity and Tolerability of Ibrutinib in Combination With Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
    Jaglowski, Samantha M.
    Jones, Jeffrey A.
    Flynn, Joseph M.
    Andritsos, Leslie A.
    Maddocks, Kami J.
    Woyach, Jennifer A.
    Blum, Kristie A.
    Greyer, Michael R.
    Geyer, Susan Michelle
    Heerema, Nyla A.
    Lozanski, Gerard
    Stefanos, Mona
    Hall, Nathan
    Nagar, Veena
    Munneke, Brian
    West, Jamie-Sue
    Neuenburg, Jutta K.
    James, Danelle F.
    Johnson, Amy J.
    Byrd, John C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S206 - S207
  • [37] Integrated and Long-Term Safety Analysis of Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 13 - 14
  • [38] Integrated and Long-Term Safety Analysis of Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
    Coutre, Steven
    Byrd, John C.
    Hillmen, Peter
    Barrientos, Jacqueline C.
    Barr, Paul M.
    Devereux, Stephen
    Robak, Tadeusz
    Kipps, Thomas J.
    Schuh, Anna
    Moreno, Carol
    Furman, Richard R.
    Burger, Jan
    O'Dwyer, Michael
    Ghia, Paolo
    Valentino, Rudolph
    Suzuki, Samuel
    Ninomoto, Joi
    James, Danelle F.
    O'Brien, Susan M.
    BLOOD, 2016, 128 (22)
  • [39] Characteristics of patients treated for CLL in a real-world registry: results from informCLL™
    Mato, Anthony
    Sharman, Jeff
    Pagel, John
    Brander, Danielle
    Kadish, Karen
    Tomlinson, Brian
    Ipe, David
    Yang, Huiying
    Arango-Hisijara, Israel
    Srivastava, Bhavini
    Schenkel, Brad
    Barrientos, Jacqueline
    LEUKEMIA & LYMPHOMA, 2017, 58 : 48 - 49
  • [40] Prognostic Testing and Treatment Approaches in Patients with Chronic Lymphocytic Leukemia: Clinical Experience from an Interim Analysis of the informCLL™ Real-World Registry
    Mato, Anthony R.
    Barrientos, Jacqueline C.
    Brander, Danielle M.
    Pagel, John M.
    Gutierrez, Meghan
    Kadish, Karen
    Tomlinson, Brian
    Ghosh, Nilanjan
    Giafis, Nick
    Ipe, David
    Upasani, Sandhya
    Sundaram, Murali
    Ferrante, Lucille
    Amaya-Chanaga, Carlos
    Iyengar, Reethi
    Sharman, Jeff
    BLOOD, 2018, 132
12345